Drug Information

Drug General Information
Drug ID
D07MQJ
Former ID
DNC013501
Drug Name
(Z)-1-(4-phenyloxazol-2-yl)octadec-9-en-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529193]
Formula
C27H39NO2
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)C1=NC(=CO1)C2=CC=CC=C2
InChI
1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-26(29)27-28-25(23-30-27)24-20-17-16-18-21-24/h9-10,16-18,20-21,23H,2-8,11-15,19,22H2,1H3/b10-9-
InChIKey
KOOKQMBHKMEODJ-KTKRTIGZSA-N
PubChem Compound ID
10070106
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529193]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.
Ref 529193Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. Epub 2007 Nov 6.Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.